1 min read
Add as a preferred source on Google

CMS Fraud Rule Proposal Omits Life Sciences and Diagnostics Companies

The proposal covers Medicare, Medicaid, CHIP and the Health Insurance Marketplace. It also includes proposed changes to Medicare Advantage audits.

A specimen vial rests beside an open, unmarked policy booklet / TokenPost.ai
A specimen vial rests beside an open, unmarked policy booklet / TokenPost.ai

The Centers for Medicare & Medicaid Services (CMS) did not mention life sciences or diagnostic companies in its proposed Medicare and Medicaid fraud rule, which also covers other federal health programs.

CMS issued the CRUSH proposal Nov. 16. It covers Medicare, Medicaid, CHIP and the Health Insurance Marketplace, while its stated fraud focus is Medicare and Medicaid. The absence of a reference to life sciences or diagnostics describes the proposal’s text; it does not establish a final policy for either sector.

The rule also includes proposed changes to Medicare Advantage risk-adjustment audits. Those changes remain proposals and are not final.

Riza Dagoc

Riza Dagoc reports on regulation, investing and the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…